Clinical Trial: ECOG-ACRIN EA3211

ECOG-ACRIN EA3211

Status: Open

Phase III Randomized Trial of Immunotherapy with or Without Consolidative Radiotherapy for Oligometastatic Head and Neck Squamous Cell Carcinoma

Eligible for screening study DCP 001